DO MIXED HISTOLOGICAL FEATURES AFFECT SURVIVAL BENEFIT FROM NEOADJUVANT PLATINUM-BASED COMBINATION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER?

2011 ◽  
Vol 108 (5) ◽  
pp. 700-700 ◽  
Author(s):  
Emil Scosyrev ◽  
Edward M. Messing
Keyword(s):  
Bladder Cancer ◽  
Combination Chemotherapy ◽  
Survival Benefit ◽  
Locally Advanced ◽  
Histological Features ◽  
Advanced Bladder Cancer

Survival Benefit Persists With Delayed Initiation of Adjuvant Chemotherapy Following Radical Cystectomy for Locally Advanced Bladder Cancer

Urology ◽  
2019 ◽  
Vol 132 ◽  
pp. 143-149 ◽  
Author(s):  
Christopher J. Corbett ◽  
Leilei Xia ◽  
Ronac Mamtani ◽  
Stanley Bruce Malkowicz ◽  
Thomas J. Guzzo
Keyword(s):  
Bladder Cancer ◽  
Adjuvant Chemotherapy ◽  
Radical Cystectomy ◽  
Survival Benefit ◽  
Locally Advanced ◽  
Advanced Bladder Cancer ◽  
Delayed Initiation

Combination Chemotherapy with Intra-Arterial Cisplatin and Doxorubicin Plus Intravenous Methotrexate and Vincristine for Locally Advanced Bladder Cancer

1995 ◽  
Vol 154 (5) ◽  
pp. 1704-1709 ◽  
Author(s):  
Seiji Naito ◽  
Toshiro Kuroiwa ◽  
Toyofumi Ueda ◽  
Kanehiro Hasuo ◽  
Kouji Masuda ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Combination Chemotherapy ◽  
Locally Advanced ◽  
Advanced Bladder Cancer
Sign in / Sign up

Export Citation Format

Share Document